Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30

$4.30+0.09 (+2.14%)

Close on Nov 13, 2026Market cap $344.88MP/E –Yield –

Atea Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Atea Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?